Management of Radiation-Induced CNS Toxicities
Improvement in cancer therapies have increased the number of long-term survivors with brain and spine tumors. While radiation therapy remains one of the cornerstones of treatment modalities, it is associated with toxicities that can impact quality of life.
Category
  • Central Nervous System
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
eContouring for Central Nervous System - In Spanish
Esta actividad educativa se centra en las técnicas de delineación de volumen en radioterapia, específicamente para tumores del sistema nervioso central.
Category
  • Central Nervous System
Format
  • Webinars
  • eContouring
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $179.00
Radiation Therapy for WHO Grade 4 Adult-Type Diffuse Glioma: An ASTRO Clinical Practice Guideline
This activity provides practitioners with the knowledge to recognize optimal RT management decisions for grade 4 glioma.
Category
  • Central Nervous System
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00
Gray Zone - Radionuclear ESCCalation: Local Therapy for Epidural Spinal Cord Compression in the Context of Peptide Receptor Radionuclide Therapy (PRRT)
The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.
Category
  • Central Nervous System
  • Radiobiology
  • SBRT
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
Cost $0.00
Updates and Challenging Cases in Pediatric Neuroblastoma and Wilms Tumor
Updates in the treatment of pediatric neuroblastoma and Wilms Tumor are presented, highlighting recent practice-changing publications and evolving study questions.
Category
  • Central Nervous System
  • Pediatric
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Radiation Therapy for Nonmalignant Conditions: Challenges and Updates
This educational series explores the evolving role of radiation therapy in managing nonmalignant conditions, addressing current challenges, emerging evidence, and specialized applications in clinical practice. Topics Covered
Category
  • Central Nervous System
  • Nonmalignant RT
Format
  • onDemand
  • Webinars
Credits
  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 Certificate of Attendance
Cost $299.00
Gray Zone - Nerve Wracking: Approaches to Locally Advanced Skull Base Adenoid Cystic Carcinoma with Extensive Perineural Spread
The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.
Category
  • Central Nervous System
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
Cost $0.00
Practical Radiation Oncology Program 2025
This program is designed to address the needs of a community practice physician and includes disease site reviews, interactive case-based discussions, a strategic dialogue with the ASTRO CEO and a radiation oncology practice overview.
Category
  • Breast
  • Central Nervous System
  • Gastrointestinal
  • Genitourinary
  • Gynecologic
  • Head and Neck
  • Sarcoma
  • SBRT
  • Skin
  • Thoracic
Format
  • onDemand
Credits
  • 12.50 AMA PRA Category 1 Credit™
  • 12.50 Certificate of Attendance
Cost $849.00
Integrating Radiation Therapy with Novel Immunotherapies in the Management of Brain Metastases and Leptomeningeal Disease
With improved systemic therapy, the management of brain metastasis has become increasingly important. A number of immunotherapies and targeted agents have shown blood brain barrier penetration with a potential role in the upfront management of brain metastases and leptomeningeal disease.
Category
  • Central Nervous System
  • Immunotherapy
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
ASTRO/SNO Joint Activity: Current Multidisciplinary Management of Molecularly Defined IDH Mutant Grade 2 - 3 Glioma - Who, What, When, Why and How?
The management of patients with grade 2 – 3 glioma has recently become even more complicated due to incorporation of molecular findings for pathologic diagnosis, changing criteria for who is considered high risk, and variability in the use and choice of chemotherapy with radiotherapy.
Category
  • Central Nervous System
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00

Pages